Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 67, Issue 11
Volume 67, Issue 11
1 December 2018
ISSN 1058-4838
EISSN 1537-6591

Volume 67, Issue 11, 1 December 2018

NEWS

Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages i–ii, https://doi.org/10.1093/cid/ciy785

IN THE LITERATURE

Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages iii–iv, https://doi.org/10.1093/cid/ciy832

ARTICLES AND COMMENTARIES

Frédérique Chammartin and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1643–1652, https://doi.org/10.1093/cid/ciy347

Retention on antiretrovirals is of concern in Africa. We analyzed outcomes in patients lost to follow-up: at 4 years after last contact, 22% had died, 23% had stopped therapy, 15% were in another clinic, and 32% could not be found.

Yingda L Xie and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1653–1659, https://doi.org/10.1093/cid/ciy365

We assessed the transmission risk of pulmonary tuberculosis patients whose sputum nucleic acid amplification tests (NAAT) were negative. We estimated that, at minimum, sputum NAAT–negative tuberculosis patients had approximately a 5% risk of transmitting tuberculosis.

Poonum S Korpe and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1660–1669, https://doi.org/10.1093/cid/ciy355

In this longitudinal multicenter study, 65% of children experienced Cryptosporidium infection during the first 2 years of life. Cryptosporidium was associated with severe diarrhea and dehydration and, in 2 South Asian sites, with stunted growth at age 2 years.

Changsheng Deng and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1670–1676, https://doi.org/10.1093/cid/ciy364

Does adding low-dose primaquine to mass drug administration of artemisinin-based combination therapy improve malaria control? On a highly endemic African island, >99% effectiveness of falciparum malaria reduction followed 3 monthly rounds of artemisinin and piperaquine, with or without low-dose primaquine.

Kalvin C Yu and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1677–1685, https://doi.org/10.1093/cid/ciy354

In this retrospective cohort of 2.7 million admissions, diagnosis-related groups, infection present on admission, unit, patient class, and history of methicillin-resistant Staphylococcus aureus/vancomycin-resistant Enterococcus were isolated as determinants of expected antimicrobial consumption in the most parsimonious model of observed-to-expected antibiotic use.

Scott K Fridkin
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1686–1687, https://doi.org/10.1093/cid/ciy359
Robert J Cybulski and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1688–1696, https://doi.org/10.1093/cid/ciy357

A multiplex polymerase chain reaction panel facilitated the more rapid institution of appropriate antimicrobial therapy in patients with acute gastroenteritis compared to traditional diagnostic methods.

Ryan Sanford and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1697–1704, https://doi.org/10.1093/cid/ciy362

Longitudinal brain changes in treated and untreated individuals with primary HIV infection were examined. Before treatment, significant brain volume loss and cortical thinning were observed. After treatment, no further brain atrophy was found. This highlights the importance of early treatment.

Kieren A Marr and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1705–1711, https://doi.org/10.1093/cid/ciy326

An immunodiagnostic assay that detects Aspergillus galactofuranose–containing antigens in urine was developed in dipstick format. Performance evaluated in a cohort of 78 subjects demonstrated good sensitivity and specificity relative to current diagnostic tests.

Constance A Benson and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1712–1719, https://doi.org/10.1093/cid/ciy242

Live attenuated herpes zoster vaccine administered to HIV-infected adults suppressed on antiretroviral therapy with CD4+ counts ≥200 cells/µL was generally safe and immunogenic. Antibody responses were similar to those observed in older adults without HIV infection who received the same vaccine.

Michael J Satlin and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1720–1728, https://doi.org/10.1093/cid/ciy363

Prior to transplant, 10% of hematopoietic stem cell transplant recipients were colonized with ESBL-producing Enterobacteriaceae (ESBL-E). In the setting of levofloxacin prophylaxis, 32% of colonized patients developed ESBL-E bacteremia during neutropenia and colonizing, and bloodstream ESBL-E were genetically identical.

Lidong Gao and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1729–1735, https://doi.org/10.1093/cid/ciy341

Our study investigated the spectrum of enteroviruses causing uncomplicated hand, foot, and mouth disease, and compared epidemiology among EV-A71, CV-A16, CV-A6, CV-A10, and CV-A4. Enterovirus diagnostic yield of different clinical samples can guide optimal sample collection for virological diagnosis.

Jeremy D Keenan and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1736–1742, https://doi.org/10.1093/cid/ciy339

Communities randomized to annual mass azithromycin distributions for trachoma had a lower prevalence of genetic macrolide resistance determinants.

Marlanka A Zuur and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1743–1749, https://doi.org/10.1093/cid/ciy346

Clinical susceptibility breakpoints for first-line antituberculosis drugs might be lower than previously thought, which means that more patients should receive second-line treatment. We propose an intermediate susceptibility dose-dependent category, which allows continued use of first-line drugs in higher doses.

Richard M Novak and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1750–1759, https://doi.org/10.1093/cid/ciy348

Syphilis incidence among persons with HIV increased from 0.4 to 2.2 per 100 person-years during 1999–2015 in a US cohort and reflects ongoing sexual risk and need for enhanced prevention interventions among HIV-infected patients in care.

Aubree Gordon and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1760–1767, https://doi.org/10.1093/cid/ciy356

Chikungunya was recently introduced into the Americas. Relatively little data exist about the introduction of chikungunya into naive populations. This study examines differences in transmission intensity and clinical severity between 2 epidemics of chikungunya in a single cohort in Nicaragua.

Jacob C Grant and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1768–1774, https://doi.org/10.1093/cid/ciy343

Haemophilus ducreyi is a major cause of skin ulcers in the tropics. On an endemic island, multiple strains of H. ducreyi cause infection, coinfections are common, and mass treatment with azithromycin did not exert selection pressure on the organism.

PHOTO QUIZ

Carlos Tornero and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1775–1776, https://doi.org/10.1093/cid/ciy282

BRIEF REPORTS

Anthony J Garcia-Prats and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1777–1780, https://doi.org/10.1093/cid/ciy416
Bianka Paquet-Bolduc and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1781–1783, https://doi.org/10.1093/cid/ciy425
Tolulope Adebanjo and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1784–1787, https://doi.org/10.1093/cid/ciy429

REVIEW ARTICLE

Andrea B Kuenzli and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1788–1795, https://doi.org/10.1093/cid/ciy443

These 2 cases of Andes hantavirus infection imported to Switzerland illustrate the challenges for intensive care physicians facing severe hantavirus cardiopulmonary syndrome and for the infection control and laboratory teams that deal with an unfamiliar and potentially human-to-human transmissible pathogen.

CORRESPONDENCE

Ravindra Kumar Garg and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1796–1797, https://doi.org/10.1093/cid/ciy434
Ethan A Smith and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Page 1797, https://doi.org/10.1093/cid/ciy435
Jon G Persichino and Loren G Miller
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1797–1798, https://doi.org/10.1093/cid/ciy436
A Clinton White and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Page 1798, https://doi.org/10.1093/cid/ciy437
Matthieu Million and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Page 1799, https://doi.org/10.1093/cid/ciy459
Erik R Dubberke and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1799–1800, https://doi.org/10.1093/cid/ciy460
Pablo Elpidio García-Granja and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Pages 1800–1801, https://doi.org/10.1093/cid/ciy444
Juan Ambrosioni and others
Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Page 1801, https://doi.org/10.1093/cid/ciy446

COVER

Clinical Infectious Diseases, Volume 67, Issue 11, 1 December 2018, Page NP, https://doi.org/10.1093/cid/ciy856
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close